ONYCHOMYCOSIS TREATMENT MARKET ANALYSIS

Regional Analysis

Based on geography, the onychomycosis treatment market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.

Among regions, North America is expected to gain highest share in the market over the forecast period owing to the rising prevalence of onychomycosis in adults/elderly population and increasing awareness among people about safe and effective treatment in the region. For instance, according to the Centers for Disease Control and Prevention (CDC), fungal nail infections, onychomycosis, are very common. They may affect up to 14% of the general population. Fungal toenail infections are more common than fungal fingernail infections. This in turn is expected to increase the demand for onychomycosis treatment in the United States.

Asia Pacific is also expected to witness significant growth in the global onychomycosis treatment market due to the increasing prevalence of onychomycosis and growing geriatric population in the region. For instance, onychomycosis is found more frequently in elderly population, and in more males than females. India’s elderly population (aged 60 and above) is expected to reach 194 million in 2031 from 138 million in 2021, a 41 per cent increase over a decade, according to the National Statistical Office (NSO)’s Elderly in India 2021 report. This in turn is expected to increase demand for onychomycosis treatment in India.

• North America: U.S. and Canada
• Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
• Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
• Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
• Middle East: GCC Countries, Israel, and Rest of Middle East
• Africa: South Africa, North Africa, and Central Africa